Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti-cholinergic Bronchodilators Versus Beta2-sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease.
Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease. Accessed February 16, 2025.
Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease
Anti-cholinergic Bronchodilators Versus Beta2-sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2025 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
ID - 450367
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450367/all/Anti_cholinergic_bronchodilators_versus_beta2_sympathomimetic_agents_for_acute_exacerbations_of_chronic_obstructive_pulmonary_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -